Search Results - "Shuster, Diana"

Refine Results
  1. 1

    Framework for the Design of Cannabis-Mediated Phase I Drug-Drug Interaction Studies by Shuster, Diana L, Pastino, Gina, Cerneus, Dirk

    “…Cannabis has become legal in much of the United States similar to many other countries, for either recreational or medical use. The use of cannabis products is…”
    Get more information
    Journal Article
  2. 2

    Clinical Pharmacokinetics of Ombitasvir by Badri, Prajakta S., Shuster, Diana L., Dutta, Sandeep, Menon, Rajeev M.

    Published in Clinical pharmacokinetics (01-10-2017)
    “…Ombitasvir is a potent, nonstructural protein 5A inhibitor of the hepatitis C virus (HCV) that is used in combination with other direct-acting antivirals for…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Variability in Expression of CYP3A5 in Human Fetal Liver by Vyhlidal, Carrie A, Pearce, Robin E, Gaedigk, Roger, Calamia, Justina C, Shuster, Diana L, Thummel, Kenneth E, Leeder, J Steven

    Published in Drug metabolism and disposition (01-08-2015)
    “…Members of the cytochrome P450 3A (CYP3A) subfamily of drug metabolizing enzymes exhibit developmental changes in expression in human liver characterized by a…”
    Get full text
    Journal Article
  5. 5

    Identification of CYP3A7 for glyburide metabolism in human fetal livers by Shuster, Diana L., Risler, Linda J., Prasad, Bhagwat, Calamia, Justina C., Voellinger, Jenna L., Kelly, Edward J., Unadkat, Jashvant D., Hebert, Mary F., Shen, Danny D., Thummel, Kenneth E., Mao, Qingcheng

    Published in Biochemical pharmacology (15-12-2014)
    “…Glyburide is commonly prescribed for the treatment of gestational diabetes mellitus; however, fetal exposure to glyburide is not well understood and may have…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Identification of Proline Residues in or near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) That Are Important for Transport Activity and Substrate Specificity by Ni, Zhanglin, Bikadi, Zsolt, Shuster, Diana L, Zhao, Chunsheng, Rosenberg, Mark F, Mao, Qingcheng

    Published in Biochemistry (Easton) (20-09-2011)
    “…The human breast cancer resistance protein (BCRP/ABCG2) confers multidrug resistance and mediates the active efflux of drugs and xenobiotics. BCRP contains one…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice by Shuster, Diana L, Bammler, Theo K, Beyer, Richard P, Macdonald, James W, Tsai, Jesse M, Farin, Frederico M, Hebert, Mary F, Thummel, Kenneth E, Mao, Qingcheng

    Published in Drug metabolism and disposition (01-02-2013)
    “…Pregnancy-induced changes in drug pharmacokinetics can be explained by changes in expression of drug-metabolizing enzymes and transporters and/or normal…”
    Get full text
    Journal Article
  11. 11

    Clinical pharmacology and tolerability of REC‐994, a redox‐cycling nitroxide compound, in randomized phase 1 dose‐finding studies by Alfa, Ron, Considine, Timothy, Virani, Shafique, Pfeiffer, Matt, Donato, Anthony, Dickerson, Daniel, Shuster, Diana, Ellis, Joel, Rushton, Kristen, Wei, Helen, Gibson, Christopher

    Published in Pharmacology research & perspectives (01-06-2024)
    “…Cerebral cavernous malformation (CCM) has variable clinical symptoms, including potentially fatal hemorrhagic stroke. Treatment options are very limited,…”
    Get full text
    Journal Article
  12. 12

    Model-Informed Optimization of a Pediatric Clinical Pharmacokinetic Trial of a New Spironolactone Liquid Formulation by Tatipalli, Manasa, Siripuram, Vijay Kumar, Long, Tao, Shuster, Diana, Bernstein, Galina, Martineau, Pierre, Cook, Kim A., Cristofoletti, Rodrigo, Schmidt, Stephan, Vozmediano, Valvanera

    Published in Pharmaceutics (08-06-2021)
    “…Quantitative pharmacology brings important advantages in the design and conduct of pediatric clinical trials. Herein, we demonstrate the application of a…”
    Get full text
    Journal Article
  13. 13

    Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age by Shuster, Diana L, Risler, Linda J, Liang, Chao-Kang J, Rice, Kenneth M, Shen, Danny D, Hebert, Mary F, Thummel, Kenneth E, Mao, Qingcheng

    “…Gestational diabetes mellitus is a major complication of human pregnancy. The oral clearance (CL) of glyburide, an oral antidiabetic drug, increases 2-fold in…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease by Bernstein, David E, Tran, Albert, Martin, Paul, Kowdley, Kris V, Bourliere, Marc, Sulkowski, Mark S, Pockros, Paul J, Renjifo, Boris, Wang, Deli, Shuster, Diana L, Cohen, Daniel E, Jacobson, Ira M

    Published in Kidney international reports (01-02-2019)
    “…Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. We performed a pooled efficacy…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Efflux transporters in drug disposition during pregnancy by Chen, Xin, Gao, Chunying, Han, Lyrialle W, Heidelberger, Sibylle, Liao, Michael Z, Neradugomma, Naveen K, Ni, Zhanglin, Shuster, Diana L, Wang, Honggang, Zhang, Yi, Zhou, Lin

    Published in Drug metabolism and disposition (29-05-2024)
    “…Evidence-based dose selection of drugs in pregnant women has been lacking due to challenges in studying maternal-fetal pharmacokinetics. Hence, many drugs are…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Gestational age‐dependent maternal‐fetal glyburide disposition in pregnant mice (1141.5) by Shuster, Diana, Risler, Linda, Liang, Jason, Rice, Kenneth, Shen, Danny, Hebert, Mary, Thummel, Kenneth, Mao, Qingcheng

    Published in The FASEB journal (01-04-2014)
    “…Glyburide (Gly) is routinely used to treat hyperglycemia during pregnancy. Our objective was to determine if maternal‐fetal disposition of Gly and metabolites…”
    Get full text
    Journal Article
  20. 20

    Identification of Proline Residues In or Near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) Important for Transport Activity and Substrate Specificity by Ni, Zhanglin, Bikadi, Zsolt, Shuster, Diana L., Zhao, Chunsheng, Rosenberg, Mark F., Mao, Qingcheng

    Published in Biochemistry (Easton) (26-08-2011)
    “…The human breast cancer resistance protein (BCRP/ABCG2) confers multidrug resistance and mediates the active efflux of drugs and xenobiotics. BCRP contains one…”
    Get full text
    Journal Article